コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 luconeogenic genes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
2 explained by increased expression of hepatic phosphoenolpyruvate carboxykinase.
3 RNA levels of the key gluconeogenetic enzyme phosphoenolpyruvate carboxykinase.
4 coneogenic enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
5 uconeogenic genes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
6 cose-6-phosphatase and the cytosolic form of phosphoenolpyruvate carboxykinase.
7 ls for the enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase.
8 eased transcription of the gene that encodes phosphoenolpyruvate carboxykinase 1 (a protein involved
9 re detail and indicated that the activity of phosphoenolpyruvate carboxykinase 1 (AT4G37870), a key e
10 nhibited hepatic gluconeogenic genes such as phosphoenolpyruvate carboxykinase 1 (Pck-1) and glucose
11 nic enzymes glucose-6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase 1 (PCK1) has negative
12 erosis/cataplerosis via genetic knockdown of phosphoenolpyruvate carboxykinase 1 (Pck1) prevented fat
13 cluding liver glycogen phosphorylase (PYGL), phosphoenolpyruvate carboxykinase 1 (PCK1), and the gluc
14 ing PEP production through overexpression of phosphoenolpyruvate carboxykinase 1 (PCK1), which bolste
15 ticoid regulated kinase 2 (SGK2) to activate phosphoenolpyruvate carboxykinase 1 (PEPCK1) and glucose
18 We determined MNR effects on fetal liver phosphoenolpyruvate carboxykinase 1 (protein, PEPCK1; ge
20 d dexamethasone-induced transcription of the phosphoenolpyruvate carboxykinase 1 gene was strikingly
21 t with TCPOBOP or PB decreased the levels of phosphoenolpyruvate carboxykinase 1 mRNA in mice but not
22 ith a glucocorticoid response element in the phosphoenolpyruvate carboxykinase 1 promoter in a hormon
23 l hepatic levels of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase 1 were increased in hP
24 the rate-limiting enzyme in gluconeogenesis, phosphoenolpyruvate carboxykinase 1, is regulated throug
25 hosphoenolpyruvate carboxykinase (PEPCK) and phosphoenolpyruvate carboxykinase 2 (PCK2) to reprogram
26 with shizukaol F decreased the expression of phosphoenolpyruvate carboxykinase 2 (PEPCK), glucose-6-p
27 lucose levels and hepatic mRNA expression of phosphoenolpyruvate carboxykinase, a well known rate-lim
28 lectron transfer flavoprotein subunit alpha, phosphoenolpyruvate carboxykinase, aconitate hydratase,
32 a not only with the rPDK4 gene but also with phosphoenolpyruvate carboxykinase and CPT-1a (carnitine
33 PST administration in KO mice stimulated phosphoenolpyruvate carboxykinase and G6Pase mRNA abunda
34 atic expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and G6Pase mRNAs was r
35 ssion of two critical gluconeogenic enzymes, phosphoenolpyruvate carboxykinase and glucose-6-phosphat
36 ession of key gluconeogenic genes, including phosphoenolpyruvate carboxykinase and glucose-6-phosphat
37 of hepatic mRNA for the cytosolic isoform of phosphoenolpyruvate carboxykinase and glucose-6-phosphat
38 ctivate key genes of gluconeogenesis such as phosphoenolpyruvate carboxykinase and glucose-6-phosphat
39 major regulators of hepatic gluconeogenesis, phosphoenolpyruvate carboxykinase and glucose-6-phosphat
41 vates expression of gluconeogenic, including phosphoenolpyruvate carboxykinase and glucose-6-phosphat
42 epatocyte genes involved in gluconeogenesis (phosphoenolpyruvate carboxykinase and glycogen synthase)
43 orrelation between dynamics and catalysis in phosphoenolpyruvate carboxykinase and other enzymes in w
45 n of the expression of two key genes: PEPCK (phosphoenolpyruvate carboxykinase) and SREBP-1c (sterol
46 e expression of liver gluconeogenic enzymes, phosphoenolpyruvate carboxykinase, and fructose-1,6-bisp
48 y acid synthase, liver-type pyruvate kinase, phosphoenolpyruvate carboxykinase, and type I deiodinase
50 pyruvate kinase), and gluconeogenic enzymes (phosphoenolpyruvate carboxykinase), as well as the diet-
51 coneogenic enzymes glucose-6 phosphatase and phosphoenolpyruvate carboxykinase, as well as a marked i
54 the nematode analog of the cytosolic form of phosphoenolpyruvate carboxykinase caused a marked extens
55 te (PEP) and oxaloacetate (OAA) by cytosolic phosphoenolpyruvate carboxykinase (cPEPCK) were investig
56 ng to the cAMP response element found in the phosphoenolpyruvate carboxykinase-cytosolic (PEPCK-C) pr
58 , transaldolase, fructose bisphosphatase and phosphoenolpyruvate carboxykinase (encoded by ICL1, MAS1
59 n increase in the liver gluconeogenic enzyme phosphoenolpyruvate carboxykinase expression and activit
61 orrelated well with the observed increase in phosphoenolpyruvate carboxykinase expression, type IA fi
62 gluconeogenic enzymes glucose-6-phosphatase, phosphoenolpyruvate carboxykinase, fructose-1,6-phosphat
63 locomplex and regulates expression of PEPCK (phosphoenolpyruvate carboxykinase), G6P (glucose-6-phosp
64 receptor substrate-1 (IRS-1), and it reduces phosphoenolpyruvate carboxykinase gene expression in a p
65 factor 1 (gAF1) and 3 (gAF3) elements in the phosphoenolpyruvate carboxykinase gene glucocorticoid re
66 rifampicin effects were also observed in the phosphoenolpyruvate carboxykinase gene that contains a f
68 cessory factor for the complete induction of phosphoenolpyruvate carboxykinase gene transcription by
69 ng response elements for insulin (in the rat phosphoenolpyruvate carboxykinase gene), glucocorticoids
71 glucose production and hepatic expression of phosphoenolpyruvate carboxykinase, glucose-6-phosphatase
72 vity in the liver of L-iNOS-Tg mice, whereas phosphoenolpyruvate carboxykinase, glucose-6-phosphatase
73 oid-regulated hepatic gluconeogenic enzymes, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase
75 iption of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (EC ) (PEPCK-C).
77 lear factor I (NFI) binds to a region of the phosphoenolpyruvate carboxykinase (GTP) (PEPCK) gene pro
79 iption of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C) (4.1.1
80 aining a chimeric gene in which the cDNA for phosphoenolpyruvate carboxykinase (GTP) (PEPCK-C) (EC 4.
83 coneogenic enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase in the leptin-infused
85 f ROR target genes, including Glc-6-Pase and phosphoenolpyruvate carboxykinase, in an ROR-dependent m
86 acted by mercaptopicolinate, an inhibitor of phosphoenolpyruvate carboxykinase, indicating that it is
87 enic enzymes fructose-1,6-bisphosphatase and phosphoenolpyruvate carboxykinase, is repressed by gluco
88 sat1 and Psph) and the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase-M (Pck2/PEPCK-M), incr
91 cokinase mRNA was decreased, whereas that of phosphoenolpyruvate carboxykinase mRNA was increased com
92 ed cAMP response element binding protein and phosphoenolpyruvate carboxykinase mRNA were profoundly r
94 (4 h) suppressed hepatic glucose production, phosphoenolpyruvate carboxykinase mRNA, and plasma FFA t
95 vity of the key gluconeogenic pathway enzyme phosphoenolpyruvate carboxykinase (Pck) also increased u
96 e (NAD) phosphate malic enzyme (NADP-ME) and phosphoenolpyruvate carboxykinase (PCK) photosynthetic p
100 ate weak interactions between MDH2 and yeast phosphoenolpyruvate carboxykinase (PCK1) and between MDH
101 pression of the hepatic gluconeogenic genes, phosphoenolpyruvate carboxykinase (PCK1) and glucose-6-p
102 n regulating glucose metabolism by targeting phosphoenolpyruvate carboxykinase (PCK1) and glucose-6-p
103 elates with glucose-6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase (PCK1) expression, key
104 these, acetylation sites (Lys19 and 514) of phosphoenolpyruvate carboxykinase (Pck1p) were determine
108 amme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-
109 gluconeogenetic and glycogenolytic enzymes, phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-
110 es that encode gluconeogenic enzymes such as phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-
111 lycemia was associated with normal levels of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-
112 d to increased transcriptional expression of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-
113 patic expression of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) and impairs in
114 The insulin response elements (IREs) of the phosphoenolpyruvate carboxykinase (PEPCK) and insulin-li
115 pts for archetypical decarboxylation enzymes phosphoenolpyruvate carboxykinase (PEPCK) and malic enzy
116 ncer cells utilize the gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and phosphoeno
117 nvestigate the effect of decreased cytosolic phosphoenolpyruvate carboxykinase (PEPCK) and plastidic
118 transcriptional regulation of Glc-6-Pase and phosphoenolpyruvate carboxykinase (PEPCK) by apoA-IV was
123 ructural studies of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) demonstrate th
125 response in two independent assays: reducing phosphoenolpyruvate carboxykinase (PEPCK) expression in
128 TP binding motif and takes a fold similar to phosphoenolpyruvate carboxykinase (PEPCK) from Escherich
129 human CYP7A1 gene in bile acid synthesis and phosphoenolpyruvate carboxykinase (PEPCK) gene in glucon
130 TTG sequence, which is the core motif of the phosphoenolpyruvate carboxykinase (PEPCK) gene IRS.
135 cyclic AMP response element (CRE) of the rat phosphoenolpyruvate carboxykinase (PEPCK) gene promoter
136 etinoic acid response element (RARE1) in the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter
140 rticoids cause a 10-fold increase in hepatic phosphoenolpyruvate carboxykinase (PEPCK) gene transcrip
142 ucocorticoid and cAMP-stimulated increase in phosphoenolpyruvate carboxykinase (PEPCK) gene transcrip
143 ular mechanisms underlying increased hepatic phosphoenolpyruvate carboxykinase (PEPCK) gene transcrip
144 ated transgenic (TG) mice overexpressing the phosphoenolpyruvate carboxykinase (PEPCK) gene under con
145 increase in the rate of transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene, which en
148 y in mice to determine the role of cytosolic phosphoenolpyruvate carboxykinase (PEPCK) in hepatic ene
149 ic gluconeogenesis through downregulation of phosphoenolpyruvate carboxykinase (PEPCK) in wild-type (
150 h enhanced activation of Akt, which inhibits phosphoenolpyruvate carboxykinase (PEPCK) induction, cau
159 ion of glucocorticoid receptor (GR) mRNA and phosphoenolpyruvate carboxykinase (PEPCK) mRNA (and acti
161 be identical with one present in the enzyme phosphoenolpyruvate carboxykinase (PEPCK) of the organis
162 ic mice that express rabbit CRP from the rat phosphoenolpyruvate carboxykinase (PEPCK) promoter in re
163 aling in renal epithelial cells, we used the phosphoenolpyruvate carboxykinase (PEPCK) promoter to ge
165 The insulin response sequence (IRS) of the phosphoenolpyruvate carboxykinase (PEPCK) promoter, loca
166 antigen (TAg), each under the control of the phosphoenolpyruvate carboxykinase (PEPCK) promoter, were
168 e pH dependence of the reaction catalyzed by phosphoenolpyruvate carboxykinase (PEPCK) provides signi
169 e structures of the rat cytosolic isoform of phosphoenolpyruvate carboxykinase (PEPCK) reported in th
171 of both glucose-6-phosphatase (Glc-6-P) and phosphoenolpyruvate carboxykinase (Pepck) to an extent s
175 eport crystal structures of the human enzyme phosphoenolpyruvate carboxykinase (PEPCK) with and witho
176 utes to TCDD suppression of transcription of phosphoenolpyruvate carboxykinase (PEPCK), a key regulat
179 receptor gamma coactivator-1 alpha (PGC-1), phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6
180 tion, expression of key gluconeogenic genes, phosphoenolpyruvate carboxykinase (PEPCK), and glucose-6
181 vestigated the role of glycerol kinase (GK), phosphoenolpyruvate carboxykinase (PEPCK), and pyruvate
182 decarboxylation of [4-(13)C]oxaloacetate via phosphoenolpyruvate carboxykinase (PEPCK), forward TCA c
183 d) could activate p38 and increase levels of phosphoenolpyruvate carboxykinase (PEPCK), glucose-6-pho
185 ough the insulin-responsive sequences of the phosphoenolpyruvate carboxykinase (PEPCK), IGFBP-1, and
186 receptor gamma co-activator-1a (PGC-1alpha), phosphoenolpyruvate carboxykinase (PEPCK), pyruvate carb
188 ted glucocorticoid induction of the gene for phosphoenolpyruvate carboxykinase (PEPCK), the rate-limi
190 pression of glucose-6-phosphatase (G6PC) and phosphoenolpyruvate carboxykinase (Pepck), two gluconeog
212 creased gluconeogenic flux through cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) and associat
214 tigated whether the mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) is the GTPas
218 colinic acid (3-MPA), a classic inhibitor of phosphoenolpyruvate carboxykinase, photosynthetic O(2) e
219 coneogenic enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, presumably, because o
220 ge-dependent phosphoenolpyruvate carboxylase/phosphoenolpyruvate carboxykinase process that decreases
221 essing rabbit CRP (CF1-CRP) regulated by the phosphoenolpyruvate carboxykinase promoter such that lev
222 SV40 T-Antigen in liver under control of the phosphoenolpyruvate carboxykinase promoter were generate
225 diate complexes of the reaction catalyzed by phosphoenolpyruvate carboxykinase provide direct structu
226 ive human TGF-beta1 under control of the rat phosphoenolpyruvate carboxykinase regulatory sequences d
227 e, transaldolase, alcohol dehydrogenase, and phosphoenolpyruvate carboxykinase) that indicate the pot
228 rboxylic acid (TCA) cycle first and then use phosphoenolpyruvate carboxykinase to initiate gluconeoge
229 of expression of several HNF3 target genes (phosphoenolpyruvate carboxykinase, transferrin, tyrosine
230 rget genes such as glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, two key targets for F
231 regulated by insulin such as those encoding phosphoenolpyruvate carboxykinase, tyrosine aminotransfe
232 ulation of PPARgamma-inducible genes such as phosphoenolpyruvate carboxykinase was maintained when ce
233 psin, aldolase B, alcohol dehydrogenase, and phosphoenolpyruvate carboxykinase, was also affected in
234 decarboxylase systems (NADP-malic enzyme and phosphoenolpyruvate carboxykinase) were critical for mat
235 gluconeogenic enzymes, isocitrate lyase and phosphoenolpyruvate carboxykinase, were also degraded in
236 and the gluconeogenesis controller, hepatic phosphoenolpyruvate carboxykinase, were significantly el
237 egulation of the first gluconeogenic enzyme, phosphoenolpyruvate carboxykinase, when acetate was the
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。